Jon E. Angell

Array ( [id] => 9582468 [patent_doc_number] => 08772471 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Targeted delivery of siRNA' [patent_app_type] => utility [patent_app_number] => 12/524536 [patent_app_country] => US [patent_app_date] => 2008-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 39 [patent_no_of_words] => 25219 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12524536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4964894 [patent_doc_number] => 20080107714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'USE OF A VECTOR COMPRISING A NUCLEIC ACID ENCODING AN ANTI-ANGIOGENIC FACTOR FOR THE TREATMENT OF CORNEAL NEOVASCULARIZATION' [patent_app_type] => utility [patent_app_number] => 12/013638 [patent_app_country] => US [patent_app_date] => 2008-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6951 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20080107714.pdf [firstpage_image] =>[orig_patent_app_number] => 12013638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5355500 [patent_doc_number] => 20090186844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'SiRNA DELIVERY INTO MAMMALIAN NERVE CELLS' [patent_app_type] => utility [patent_app_number] => 11/972376 [patent_app_country] => US [patent_app_date] => 2008-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16531 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186844.pdf [firstpage_image] =>[orig_patent_app_number] => 11972376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5416939 [patent_doc_number] => 20090042826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Use of the AXL receptor for diagnosis and treatment of renal disease' [patent_app_type] => utility [patent_app_number] => 12/006999 [patent_app_country] => US [patent_app_date] => 2008-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18560 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042826.pdf [firstpage_image] =>[orig_patent_app_number] => 12006999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11225504 [patent_doc_number] => 09453219 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-27 [patent_title] => 'Cosmetic designs and products using intronic RNA' [patent_app_type] => utility [patent_app_number] => 12/003662 [patent_app_country] => US [patent_app_date] => 2007-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21379 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12003662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6616990 [patent_doc_number] => 20100099746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'NOVEL NUCLEIC ACID' [patent_app_type] => utility [patent_app_number] => 12/519960 [patent_app_country] => US [patent_app_date] => 2007-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 46305 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099746.pdf [firstpage_image] =>[orig_patent_app_number] => 12519960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4845467 [patent_doc_number] => 20080181875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'USE OF CYCLOPHILIN AS ANTIOXIDANT AND PREVENTION OF CYCLOSPORIN A-INDUCED TOXICITY IN CELL TRANSPLANTATION BY OVEREXPRESSION OF CYCLOPHILIN' [patent_app_type] => utility [patent_app_number] => 11/954334 [patent_app_country] => US [patent_app_date] => 2007-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 12169 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20080181875.pdf [firstpage_image] =>[orig_patent_app_number] => 11954334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4873680 [patent_doc_number] => 20080200414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'HCaRG, A Novel Calcium-Regulated Gene' [patent_app_type] => utility [patent_app_number] => 11/938894 [patent_app_country] => US [patent_app_date] => 2007-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15411 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200414.pdf [firstpage_image] =>[orig_patent_app_number] => 11938894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4927361 [patent_doc_number] => 20080166724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'VEGF-Modulated Genes and Methods Employing Them' [patent_app_type] => utility [patent_app_number] => 11/932133 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 45832 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20080166724.pdf [firstpage_image] =>[orig_patent_app_number] => 11932133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4613181 [patent_doc_number] => 07989428 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => 'Combined telomerase inhibitor and gemcitabine for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 12/446931 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8546 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/989/07989428.pdf [firstpage_image] =>[orig_patent_app_number] => 12446931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 203024 [patent_doc_number] => 07632939 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-15 [patent_title] => 'siRNA targeting proto-oncogene MET' [patent_app_type] => utility [patent_app_number] => 11/980263 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34388 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/632/07632939.pdf [firstpage_image] =>[orig_patent_app_number] => 11980263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4903958 [patent_doc_number] => 20080113371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'siRNA targeting beta secretase (BACE)' [patent_app_type] => utility [patent_app_number] => 11/978457 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 34653 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113371.pdf [firstpage_image] =>[orig_patent_app_number] => 11978457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4498534 [patent_doc_number] => RE042524 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2011-07-05 [patent_title] => 'Colloidal metal compositions and methods' [patent_app_type] => reissue [patent_app_number] => 11/923344 [patent_app_country] => US [patent_app_date] => 2007-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 10 [patent_no_of_words] => 20697 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/042/RE042524.pdf [firstpage_image] =>[orig_patent_app_number] => 11923344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5231345 [patent_doc_number] => 20070293453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Combinatorial Methods For Inducing Cancer Cell Death' [patent_app_type] => utility [patent_app_number] => 11/839314 [patent_app_country] => US [patent_app_date] => 2007-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 20647 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20070293453.pdf [firstpage_image] =>[orig_patent_app_number] => 11839314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6232019 [patent_doc_number] => 20100184833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'METHODS AND MEANS FOR TREATING DNA REPEAT INSTABILITY ASSOCIATED GENETIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/377160 [patent_app_country] => US [patent_app_date] => 2007-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9833 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184833.pdf [firstpage_image] =>[orig_patent_app_number] => 12377160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289721 [patent_doc_number] => 20100158869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'COMPOSITIONS, DEVICES AND METHODS FOR TREATMENT OF HUNTINGTON\'S DISEASE THROUGH INTRACRANIAL DELIVERY OF SIRNA' [patent_app_type] => utility [patent_app_number] => 12/376940 [patent_app_country] => US [patent_app_date] => 2007-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14189 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158869.pdf [firstpage_image] =>[orig_patent_app_number] => 12376940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4764608 [patent_doc_number] => 20080175819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'VECTOR SYSTEM' [patent_app_type] => utility [patent_app_number] => 11/834649 [patent_app_country] => US [patent_app_date] => 2007-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 22909 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20080175819.pdf [firstpage_image] =>[orig_patent_app_number] => 11834649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6375763 [patent_doc_number] => 20100076053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'SEQUENCE OF DSRNA: ATN-RNA, INTERVENTION USING IRNAI, USE OF A SEQUENCE OF DSRNA: ATN-RNA, A METHOD OF TREATING AND INHIBITING A BRAIN TUMOR, A KIT FOR INHIBITING CANCER CELL WHICH EXPRESSES TENASCIN, A METHOD FOR A KIT PREPARATION IN A BRAIN TUMOR THERAPY' [patent_app_type] => utility [patent_app_number] => 12/375916 [patent_app_country] => US [patent_app_date] => 2007-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7840 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20100076053.pdf [firstpage_image] =>[orig_patent_app_number] => 12375916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4688975 [patent_doc_number] => 20080033156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'Polycationic compositions for cellular delivery of polynucleotides' [patent_app_type] => utility [patent_app_number] => 11/879470 [patent_app_country] => US [patent_app_date] => 2007-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 33073 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20080033156.pdf [firstpage_image] =>[orig_patent_app_number] => 11879470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765741 [patent_doc_number] => 20080176953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Methods and compositions for treatment of ocular neovascularization and neural injury' [patent_app_type] => utility [patent_app_number] => 11/879187 [patent_app_country] => US [patent_app_date] => 2007-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5720 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176953.pdf [firstpage_image] =>[orig_patent_app_number] => 11879187 [rel_patent_id] =>[rel_patent_doc_number] =>)